home-page-logo

From Concept to Clinic
to the Commercial Market.

YOUR RADIOPHARMACEUTICAL DEVELOPMENT PARTNER.

At CPDC we are working with our partners to discover, develop and distribute the next generation of imaging agents and targeted radiotherapeutics for the detection and treatment of human diseases.

What Are Radiopharmaceuticals?

Radiopharmaceuticals are a special class of drugs. They’re sometimes called molecular imaging probes, contrast agents, tracers or radiotherapeutics.

Radiopharmaceuticals contain a radioactive isotope and they are used to both diagnose and treat disease.  Millions of patients receive radiopharmaceuticals annually for a wide variety of medical procedures ranging from the assessment of cardiac function to staging and treatment of cancer.

CPDC Announces Four New Appointments To Board of Directors

HAMILTON, ON, July 13, 2021 – The Centre for Probe Development and Commercialization (CPDC), a global leader in the development, production and commercialization of radiopharmaceuticals, announced today that it has appointed four new Members to join its Board of Directors effective June 17, 2021.  The new Members are as follows: Dr. Bettina Hamelin, is the current President and

Do you love radiopharmaceuticals as much as we do?

CPDC is always looking for exceptional people to strengthen our team.

Join Our Team

For more information contact us at: